Protea Fund-Veritas High Equity A Acc GBP

Reference Data

ISIN LU1901191145
Valor Number 44433882
Bloomberg Global ID
Fund Name Protea Fund-Veritas High Equity A Acc GBP
Fund Provider FundPartner Solutions (Europe) S.A
Fund Provider FundPartner Solutions (Europe) S.A
Representative in Switzerland FundPartner Solutions (Suisse) SA
Genève 75
Distributor(s) FundPartner Solutions (Suisse) SA
Genève 3
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The Compartment’s objective is to protect and grow the purchasing power of investors’ capital over the long term by seeking global opportunities for real returns and investing on a best ideas, unindexed basis.
Peculiarities

Fund Prices

Current Price * 177.16 GBP 17.04.2025
Previous Price * 179.05 GBP 16.04.2025
52 Week High * 206.16 GBP 23.01.2025
52 Week Low * 175.77 GBP 07.04.2025
NAV * 177.16 GBP 17.04.2025
Issue Price * 177.16 GBP 17.04.2025
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 724,355,720
Unit/Share Assets *** 352,286,108
Trading Information SIX

Performance

YTD Performance -8.55% 31.12.2024
17.04.2025
YTD Performance (in CHF) -12.46% 31.12.2024
17.04.2025
1 month -5.11% 17.03.2025
17.04.2025
3 months -12.67% 17.01.2025
17.04.2025
6 months -7.39% 17.10.2024
17.04.2025
1 year -0.11% 17.04.2024
17.04.2025
2 years +10.65% 17.04.2023
17.04.2025
3 years +11.59% 19.04.2022
17.04.2025
5 years +57.20% 17.04.2020
17.04.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Fiserv Inc 4.64%
UnitedHealth Group Inc 4.63%
Mastercard Inc Class A 3.95%
London Stock Exchange Group PLC 3.88%
Intuitive Surgical Inc 3.85%
Marsh & McLennan Companies Inc 3.71%
Thermo Fisher Scientific Inc 3.54%
Microsoft Corp 3.51%
Intuit Inc 3.36%
Synopsys Inc 3.33%
Last data update 31.10.2024

Cost / Risk

TER *** 0.75%
TER date *** 31.03.2025
Performance Fee ***
PTR
Max. Management Fee *** 0.60%
Ongoing Charges *** 0.75%
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)